The DOI matches its Crossref record; 74 of the 74 references it cites were found in a registry or an index.
Drugs of abuse: anatomy, pharmacology and function of reward pathways
Abstract
Drugs of abuse are very powerful reinforcers, and even in conditions of limited access (where the organism is not dependent) these drugs will motivate high rates of operant responding. This presumed hedonic property and the drugs' neuropharmacological specificity provide a means of studying the neuropharmacology and neuroanatomy of brain reward. Three major brain systems appear to be involved in drug reward--dopamine, opioid and GABA. Evidence suggests a midbrain-forebrain-extrapyramidal circuit with its focus in the nucleus accumbens. Data implicating dopamine and opioid systems in indirect sympathomimetic and opiate reward include critical elements in both the nucleus accumbens and ventral tegmental areas. Ethanol reward appears to depend on an interaction with the GABAA receptor complex but may also involve common elements such as dopamine and opioid peptides in this midbrain-forebrain-extrapyramidal circuit. These results suggest that brain reward systems have a multidetermined neuropharmacological basis that may involve some common neuroanatomical elements.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In addition, there is extensive experimental evidence in animal contexts supporting a role for the mesolimbic reward pathway on appetitive and motivational behaviors [306,307].”
From Reward circuitry dysfunction in psychiatric and neurodevelopmental disorders and genetic syndromes: animal models and clinical findings (2012) · cites this paper as [307]
In the citing paper
“The meso-limbic dopamine system that projects from the ventral tegmental area (VTA) to the nucleus accumbens has been implicated in the rewarding effects of drugs of abuse”
From Dopamine reward circuitry: Two projection systems from the ventral midbrain to the nucleus accumbens–olfactory tubercle complex (2007) · cites this paper as Koob, 1992
Citations
Cites
Handbook of Psychopharmacology
Iversen, L. L., Iversen, S. D., & Snyder, S. H. (1988) · Springer eBooks · doi:10.1007/978-1-4613-0933-8 · Cited by 2,756
A psychomotor stimulant theory of addiction.
Wise, R. A., & Bozarth, M. A. (1987) · Psychological Review · doi:10.1037/0033-295x.94.4.469 · Cited by 2,747
From motivation to action: Functional interface between the limbic system and the motor system
MOGENSON, G., JONES, D., & YIM, C. (1980) · Progress in Neurobiology · doi:10.1016/0301-0082(80)90018-0 · Cited by 2,331
Cellular and molecular mechanisms of drug dependence
Koob, G. F., & Bloom, F. E. (1988) · Science · doi:10.1126/science.2903550 · Cited by 2,070
Self-citationWise, R. A., & Rompre, P.-P. (1989) · Annual Review of Psychology · doi:10.1146/annurev.ps.40.020189.001203 · Cited by 1,968
An opponent-process theory of motivation. I. Temporal dynamics of affect
Solomon, R. L., & Corbit, J. D. (1974) · Psychological Review · doi:10.1037/h0036128 · Cited by 1,704
Alheid, G. F., & Heimer, L. (1988) · Neuroscience · doi:10.1016/0306-4522(88)90217-5 · Cited by 1,217
Fallon, J. H., & Moore, R. Y. (1978) · The Journal of Comparative Neurology · doi:10.1002/cne.901800310 · Cited by 1,190
Mesocorticolimbic dopaminergic network: functional and regulatory roles
Moal, M. L., & Simon, H. (1991) · Physiological Reviews · doi:10.1152/physrev.1991.71.1.155 · Cited by 1,108
Di Chiara, G., & Imperato, A. (1988) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)24578-5 · Cited by 916
Research works printed but not linked: 21
- Dahlström, 1964, Acta Physiol. Scand., 232, 1
- Weiss, F. et al.Ann. NY Acad. Sci. (in press).
- Pfeffer, 1985, Alcohol Drug Res., 6, 37
- Rassnick, S., Pulvirenti, L. and Koob, G. F. Psychopharmacology (in press).
- Samson, 1988, Alcohol. Clin. Exp. Res., 12, 581
- Imperato, 1986, J. Pharmacol. Exp. Ther., 239, 221
- Bodnar, 1990, Crit. Rev. Neurobiol., 6, 39
- West, 1989, Soc. Neurosri. Abstr., 15, 20.8
- Koob, 1984, J. Pharmacol. Exp. Ther., 229, 481
- Goldberg, 1971, J. Pharmacol. Exp. Ther., 176, 464
- Di Chiara, 1988, J. Pharmacol. Exp. Ther., 244, 1067
- Di Chiara, 1988, 85, 5274
- Shippenberg, T. S., Spanagel, R. and Herz, A.Ann. NY Acad. Sci. (in press).
- Givens, 1990, J. Pharmacol. Exp. Ther., 254, 528
- Sepinwall, 1978, Vol. 13, 345
- Koob, G. F. and Britton, K. T. in Pharmacology and Neuropharmacology (Vol. 2) Alcohol and Alcoholisms (Begleiter, H. and Kissin, B., eds), Oxford University Press (in press).
- Frye, 1982, J. Pharmacol. Exp. Ther., 223, 750
- Suzdak, 1986, 83, 4071
- Rassnick, S. et al.Ann. NY Acad. Sci. (in press).
- Deitrich, 1989, Pharmacol. Rev., 41, 489
- Pickens, 1981, J. Pharmacol. Exp. Ther., 216, 205
Cited by
Sorted by citations
Items 701–800 of 1,004
Justinová, Z., Ferré, S., Redhi, G. H., Mascia, P., Stroik, J., Quarta, D., Yaşar, S., Müller, C. E., Franco, R., & Goldberg, S. R. (2010) · Addiction Biology · doi:10.1111/j.1369-1600.2010.00258.x · Cited by 58
Role of amygdala in drug memory
Luo, Y., Xue, Y.-X., Shen, H., & Lü, L. (2013) · Neurobiology of Learning and Memory · doi:10.1016/j.nlm.2013.06.017 · Cited by 59
Johann, M., Putzhammer, A., Eichhammer, P., & Wodarz, N. (2004) · American Journal of Medical Genetics Part B Neuropsychiatric Genetics · doi:10.1002/ajmg.b.30085 · Cited by 58
Georges, F. E., Stinus, L., & Moine, C. L. (2000) · European Journal of Neuroscience · doi:10.1046/j.0953-816x.2000.01334.x · Cited by 58
Association between the dopamine D2 receptor A2/A2 genotype and smoking behavior in the Japanese.
Yoshida, K., Hamajima, N., Ki, K., Saito, H., Maeno, K., Sugiura, T., Okuma, K., & Takahashi, T. (2001) · PubMed · Cited by 58
Todtenkopf, M. S., Mihalakopoulos, A., & Stellar, J. R. (2002) · Neuroscience · doi:10.1016/s0306-4522(02)00272-5 · Cited by 58
Synthetic Cathinones and Their Rewarding and Reinforcing Effects in Rodents
Watterson, L. R., & Olive, M. F. (2014) · Advances in Neuroscience · doi:10.1155/2014/209875 · Cited by 57
The Dopamine Transporter: A Vigilant Border Control for Psychostimulant Action
Williams, J. M., & Galli, A. (2006) · Springer eBooks · doi:10.1007/3-540-29784-7_11 · Cited by 57
WILLIAMS, J., STAFFORD, D., & Steketee, J. D. (2004) · Neurochemistry International · doi:10.1016/j.neuint.2004.07.006 · Cited by 57
Mayerhofer, A., Kovar, K., & Schmidt, W. (2001) · Neuroscience Letters · doi:10.1016/s0304-3940(01)01992-9 · Cited by 57
Nowak, K., McBride, W. J., Lumeng, L., Li, T., & Murphy, J. M. (2000) · Alcoholism Clinical and Experimental Research · doi:10.1097/00000374-200004000-00021 · Cited by 57
The development of opiate addiction in the rat
Heyne, A. (1996) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(95)00193-x · Cited by 57
Yim, H. J., Robinson, D. L., White, M. L., Jaworski, J. N., Randall, P. K., Lancaster, F. E., & Gonzales, R. A. (2000) · Alcoholism Clinical and Experimental Research · doi:10.1111/j.1530-0277.2000.tb02056.x · Cited by 57
Werme, M., Thorén, P., Olson, L., & Brené, S. (1999) · Journal of Neuroscience · doi:10.1523/jneurosci.19-14-06169.1999 · Cited by 57
Insights to drug addiction derived from ultrastructural views of the mesocorticolimbic system
Morales, M., & Pickel, V. M. (2011) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2011.06299.x · Cited by 56
Zhang, G., Mao, L., Liu, X., & Wang, J. Q. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2007.04748.x · Cited by 56
Nolan, R. A., Muir, R., Runner, K., Haddad, E. K., & Gaskill, P. J. (2018) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-018-9825-2 · Cited by 56
Warneke, W., Klaus, S., Fink, H., Langley‐Evans, S. C., & Voigt, J. (2013) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2013.11.016 · Cited by 56
Dorsal hippocampal muscarinic and nicotinic receptors are involved in mediating morphine reward
Rezayof, A., ذاتعلی, ه., HAERIROHANI, A., & Zarrindast, M. (2005) · Behavioural Brain Research · doi:10.1016/j.bbr.2005.08.010 · Cited by 56
Serotonergic and Noradrenergic Function in Pathological Gambling
DeCaria, C. M., Begaz, T., & Hollander, E. (1998) · CNS Spectrums · doi:10.1017/s1092852900006003 · Cited by 56
Lee, K. P., & Kornetsky, C. H. (1998) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(98)00020-3 · Cited by 56
PHARMACOTHERAPY FOR OPIOID AND COCAINE ABUSE
Warner, E. A., Kosten, T. R., & O’Connor, P. G. (1997) · Medical Clinics of North America · doi:10.1016/s0025-7125(05)70555-1 · Cited by 56
Erdtmann-Vourliotis, M., Mayer, P. E., Riechert, U., & Höllt, V. (1999) · Molecular Brain Research · doi:10.1016/s0169-328x(99)00207-7 · Cited by 56
Abrahamsen, G. C., Berman, Y. L., & Carr, K. D. (1995) · Brain Research · doi:10.1016/0006-8993(95)00764-h · Cited by 56
Corda, M. G., Lecca, D., Piras, G., Chiara, G. D., & Giorgi, O. (1997) · Behavior Genetics · doi:10.1023/a:1021452814574 · Cited by 56
Diet-induced obesity increases μ opioid receptor binding in specific regions of the rat brain
Smith, S. L., Harrold, J. A., & Williams, G. (2002) · Brain Research · doi:10.1016/s0006-8993(02)03291-2 · Cited by 55
Naltrexone Suppresses Ethanol Intake in 6-Hydroxydopamine???Treated Rats
Koistinen, M., Tuomainen, P. M., Hyytiä, P., & Kiianmaa, K. (2001) · Alcoholism Clinical and Experimental Research · doi:10.1097/00000374-200111000-00008 · Cited by 55
Beyer, C. E., Stafford, D. A., LeSage, M. G., Glowa, J. R., & Steketee, J. D. (2001) · Psychopharmacology · doi:10.1007/s002130000614 · Cited by 55
Contribution of monoamine oxidase (MAO) inhibition to tobacco and alcohol addiction
van Amsterdam, J., Talhout, R., Vleeming, W., & Opperhuizen, A. (2006) · Life Sciences · doi:10.1016/j.lfs.2006.06.010 · Cited by 55
Hutchison, K. E., NIAURA, R. S., & Swift, R. M. (1999) · Experimental and Clinical Psychopharmacology · doi:10.1037//1064-1297.7.3.250 · Cited by 55
Yamaguchi, H., Aiba, A., Nakamura, K. D., Nakao, K., Sakagami, H., Goto, K., Kondo, H., & Katsuki, M. (1996) · Genes to Cells · doi:10.1046/j.1365-2443.1996.d01-238.x · Cited by 54
Uzbay, T. I., Usanmaz, S. E., Tapanyigit, E. E., Aynacıoğlu, Ş., & Akarsu, E. S. (1998) · Drug and Alcohol Dependence · doi:10.1016/s0376-8716(98)00102-1 · Cited by 54
Niwa, M., Nitta, A., Yamada, Y., Nakajima, A., Saito, K., Seishima, M., Shen, L., Noda, Y., Furukawa, S., & Nabeshima, T. (2007) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.06.016 · Cited by 54
Sahraei, H., Ghoshooni, H., Salimi, S. H., Astani, A. M., Shafaghi, B., Falahi, M., & Kamalnegad, M. (2002) · Journal of Ethnopharmacology · doi:10.1016/s0378-8741(02)00012-0 · Cited by 54
Cocaine Is Self‐administered into the Shell Region of the Nucleus Accumbens in Wistar Rats
McKinzie, D. L., Rodd, Z. A., DAGON, C. T., MURPHY, J. M., & McBride, W. J. (1999) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1999.tb09323.x · Cited by 54
Powell, K. R., & Holtzman, S. G. (2001) · Drug and Alcohol Dependence · doi:10.1016/s0376-8716(00)00167-8 · Cited by 54
Combination Pharmacotherapy for Stopping Smoking: What Advantages Does it Offer?
Ebbert, J. O., Hays, J. T., & Hurt, R. D. (2010) · Drugs · doi:10.2165/11536100-000000000-00000 · Cited by 53
Inhibition of GSK3 attenuates amphetamine-induced hyperactivity and sensitization in the mouse
Enman, N. M., & Unterwald, E. M. (2012) · Behavioural Brain Research · doi:10.1016/j.bbr.2012.03.027 · Cited by 53
Engel, J. A., & Jerlhag, E. (2014) · Progress in brain research · doi:10.1016/b978-0-444-63425-2.00009-x · Cited by 53
Caenorhabditis elegans as a Model to Study the Molecular and Genetic Mechanisms of Drug Addiction
Engleman, E. A., Katner, S. N., & Neal‐Beliveau, B. S. (2015) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2015.10.019 · Cited by 53
Giorgi, O., Corda, M. G., Carboni, G., Frau, V., Valentini, V., & Chiara, G. D. (1997) · Behavior Genetics · doi:10.1023/a:1021405031412 · Cited by 53
Garcia-Ladona, F. J., & Cox, B. F. (2003) · CNS Drug Reviews · doi:10.1111/j.1527-3458.2003.tb00246.x · Cited by 53
Attenuation of some subjective effects of amphetamine following tyrosine depletion
McTavish, S. F. B., McPherson, M. H., Sharp, T., & Cowen, P. J. (1999) · Journal of Psychopharmacology · doi:10.1177/026988119901300205 · Cited by 53
Adenosine A2A receptors and their role in drug addiction
Brown, R. M., & Short, J. L. (2008) · Journal of Pharmacy and Pharmacology · doi:10.1211/jpp.60.11.0001 · Cited by 53
Thomas, E. A. (2009) · Molecular Neurobiology · doi:10.1007/s12035-009-8067-y · Cited by 54
Conditioned fear stress induces ethanol-associated place preference in rats
Matsuzawa, S., Suzuki, T., & Misawa, M. (1998) · European Journal of Pharmacology · doi:10.1016/s0014-2999(97)01456-8 · Cited by 53
Werme, M., Olson, L., & Brené, S. (2000) · Molecular Brain Research · doi:10.1016/s0169-328x(99)00327-7 · Cited by 53
de Waele, J., & Gianoulakis, C. (1997) · Alcoholism Clinical and Experimental Research · doi:10.1111/j.1530-0277.1997.tb03834.x · Cited by 53
Adolescent kleptomania treated with naltrexone
Grant, J. E., & Kim, S. W. (2002) · European Child & Adolescent Psychiatry · doi:10.1007/s007870200016 · Cited by 52
Maldonado, R. J. (2003) · Springer eBooks · doi:10.1007/978-3-7091-0541-2_1 · Cited by 52
Orío, L., Wee, S., Newman, A. H., Pulvirenti, L., & Koob, G. F. (2010) · Addiction Biology · doi:10.1111/j.1369-1600.2010.00211.x · Cited by 52
Self-citationThe preclinical pharmacologic profile of tiapride
Scatton, B., Cohen, C., Perrault, G., Oblin, A., Claustre, Y., Schoemaker, H., Sanger, D. J., Rouquier, L., & Porsolt, R. D. (2001) · European Psychiatry · doi:10.1016/s0924-9338(00)00526-5 · Cited by 52
Naneix, F., Marchand, A. R., Pichon, A., Pape, J., & Coutureau, É. (2013) · Neuropsychopharmacology · doi:10.1038/npp.2013.55 · Cited by 52
Serotonin (5-hydroxytryptamine) 5-HT2A receptor
Anastasio, N. C., Stoffel, E. C., Fox, R. G., Bubar, M. J., Rice, K. C., Moeller, F. G., & Cunningham, K. A. (2011) · Behavioural Pharmacology · doi:10.1097/fbp.0b013e328345f90d · Cited by 52
Behaviors induced or disrupted by complex partial seizures
Leung, L.-W. S., Ma, J., & McLachlan, R. S. (2000) · Neuroscience & Biobehavioral Reviews · doi:10.1016/s0149-7634(00)00035-x · Cited by 52
Edvardsson, C. E., Vestlund, J., & Jerlhag, E. (2021) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2021.174039 · Cited by 52
Belujon, P., Jakobowski, N. L., Dollish, H. K., & Grace, A. A. (2015) · Neuropsychopharmacology · doi:10.1038/npp.2015.191 · Cited by 52
Matsuzawa, S., Suzuki, T., & Misawa, M. (2000) · Alcoholism Clinical and Experimental Research · doi:10.1111/j.1530-0277.2000.tb04624.x · Cited by 52
Bardo, M. T., Robinet, P. M., & HAMMER, R. F. (1997) · Neuropharmacology · doi:10.1016/s0028-3908(96)00139-6 · Cited by 52
Effects of morphine, naloxone and their interaction in the learned-helplessness paradigm in rats
Besson, A., Privat, A. M., Fialip, J., & Eschalier, A. (1996) · Psychopharmacology · doi:10.1007/bf02246283 · Cited by 52
Lamas, X., Negus, S. S., Mello, N. K., & Nader, M. A. (1996) · Psychopharmacology · doi:10.1007/bf02247435 · Cited by 52
Singh, M. E., McGregor, I. S., & Mallet, P. E. (2005) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300770 · Cited by 52
Enrico, P., Mura, M. A., Esposito, G., Serra, P. A., Migheli, R., Natale, G. D., Desole, M. S., Miele, M., & MIELE, E. (1998) · Brain Research · doi:10.1016/s0006-8993(98)00371-0 · Cited by 52
Nicotinic receptors co-localize with 5-HT3 serotonin receptors on striatal nerve terminals
Nayak, S. V., Rondé, P., Spier, A. D., Lummis, S. C. R., & Nichols, R. A. (2000) · Neuropharmacology · doi:10.1016/s0028-3908(00)00109-x · Cited by 52
Effects of a range of dopamine receptor agonists and antagonists on ethanol intake in the rat
Silvestre, J. S., O‘Neill, M. F., Fernández, A. G., & Palacios, J. M. (1996) · European Journal of Pharmacology · doi:10.1016/s0014-2999(96)00821-7 · Cited by 52
Airavaara, M., Mijatovic, J., Vihavainen, T., Piepponen, P. T., Saarma, M., & Ahtee, L. (2006) · Synapse · doi:10.1002/syn.20245 · Cited by 51
Endocannabinoids Promote Cocaine-Induced Impulsivity and Its Rapid Dopaminergic Correlates
Hernández, G., Oleson, E. B., Gentry, R. N., Abbas, Z., Bernstein, D. L., Arvanitogiannis, A., & Cheer, J. F. (2013) · Biological Psychiatry · doi:10.1016/j.biopsych.2013.09.005 · Cited by 51
Baracz, S. J., Parker, L. M., Suraev, A. S., Everett, N. A., Goodchild, A. K., McGregor, I. S., & Cornish, J. L. (2015) · Journal of Neuroendocrinology · doi:10.1111/jne.12337 · Cited by 51
Riegel, A. C., & French, E. D. (1999) · Pharmacology & Toxicology · doi:10.1111/j.1600-0773.1999.tb01061.x · Cited by 51
Carey, R. J., DEPALMA, G., & Damianopoulos, E. N. (2004) · Behavioural Brain Research · doi:10.1016/j.bbr.2004.09.012 · Cited by 51
Pulvirenti, L., Balducci, C., Piercy, M., & Koob, G. F. (1998) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)37716-x · Cited by 51
Self-citationMitrovic, I., & Napier, T. C. (1998) · Brain Research · doi:10.1016/s0006-8993(98)00130-9 · Cited by 51
Anseloni, V. C. Z., Coimbra, N. C., Morato, S., & Brandão, M. L. (1999) · Experimental Brain Research · doi:10.1007/s002210050896 · Cited by 51
Tumor Necrosis Factor-α and Its Inducer Inhibit Morphine-Induced Rewarding Effects and Sensitization
Niwa, M., Nitta, A., Yamada, Y., Nakajima, A., Saito, K., Seishima, M., Noda, Y., & Nabeshima, T. (2007) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.10.009 · Cited by 51
Brain Reward System Activity in Major Depression and Comorbid Nicotine Dependence
Cárdenas, L., Tremblay, L. K., Naranjo, C. A., Herrmann, N., Zack, M. H., & Busto, U. E. (2002) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.302.3.1265 · Cited by 51
Neuroadaptive Changes in NMDAR1 Gene Expression after Extinction of Cocaine Self‐Administration
CRESPO, J. A., Oliva, J. M., Ghasemzadeh, M. B., Kalivas, P. W., & Ambrosio, E. (2002) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2002.tb04153.x · Cited by 51
Brain Reward Circuits in Alcoholism
Koob, G. F., & Roberts, A. J. (1999) · CNS Spectrums · doi:10.1017/s1092852900011196 · Cited by 51
Self-citationHodge, C. W., Samson, H. H., Tolliver, G. A., & Haraguchi, M. (1994) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(94)90510-x · Cited by 51
Chronic nicotine administration in the drinking water affects the striatal dopamine in mice
Pietilä, K., & Ahtee, L. (2000) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(00)00235-5 · Cited by 50
Zhao, X., Seese, R. R., Yun, K., Peng, T., & Wang, Z. (2013) · Neuroscience · doi:10.1016/j.neuroscience.2013.04.046 · Cited by 50
Vásquez, C. E., Riener, R. M., Reynolds, E., & Britton, G. B. (2014) · Neurochemistry International · doi:10.1016/j.neuint.2014.09.007 · Cited by 50
Sahr, A. E., Sindelar, D. K., Alexander-Chacko, J. T., Eastwood, B. J., Mitch, C. H., & Statnick, M. A. (2008) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00390.2007 · Cited by 50
The role of catecholamines in HIV neuropathogenesis
Nolan, R. A., & Gaskill, P. J. (2018) · Brain Research · doi:10.1016/j.brainres.2018.04.030 · Cited by 50
Bossert, J. M., Hoots, J. K., Fredriksson, I., Adhikary, S., Zhang, M., Vènniro, M., & Shaham, Y. (2018) · European Journal of Neuroscience · doi:10.1111/ejn.13955 · Cited by 50
Sesack, S. R., & Pickel, V. M. (1995) · Brain Research · doi:10.1016/0006-8993(94)01391-t · Cited by 50
Rowlett, J. K., Platt, D. M., Yao, W., & Spealman, R. D. (2007) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.107.120766 · Cited by 50
Rezayof, A., Razavi, S., Haeri-Rohani, A., Rassouli, Y., & Zarrindast, M. (2006) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2006.02.003 · Cited by 50
Rezvani, A. H., & Levin, E. D. (2004) · International Journal of Developmental Neuroscience · doi:10.1016/j.ijdevneu.2004.03.007 · Cited by 50
Fuertes, G., Laorden, M. L., & Milanés, M. V. (2000) · Neuroendocrinology · doi:10.1159/000054521 · Cited by 50
Decreased Ethanol Preference and Consumption in Dopamine Transporter Female Knock-Out Mice
Savelieva, K. V., Caudle, W. M., Findlay, G. S., Caron, M. G., & Miller, G. W. (2002) · Alcoholism Clinical and Experimental Research · doi:10.1111/j.1530-0277.2002.tb02602.x · Cited by 50
Centrally administered galanin blocks morphine place preference in the mouse
Zachariou, V., Parikh, K., & Picciotto, M. R. (1999) · Brain Research · doi:10.1016/s0006-8993(99)01476-6 · Cited by 50
Abused Inhalants and Central Reward Pathways
Riegel, A. C., & French, E. D. (2002) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2002.tb04170.x · Cited by 50
Hodge, C. W. (1996) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(95)02146-9 · Cited by 50
Excitatory actions of serotonin on GABAergic neurons of the medial septum and diagonal band of broca
Alreja, M. (1996) · Synapse · doi:10.1002/(sici)1098-2396(199601)22:1 · Cited by 67
Quintanilla, M. E., Perez, E., & Tampier, L. (2008) · Addiction Biology · doi:10.1111/j.1369-1600.2008.00102.x · Cited by 49
Lin, D. C.-H., Bruijnzeel, A. W., Schmidt, P., & Markou, A. (2002) · Neuroscience · doi:10.1016/s0306-4522(02)00366-4 · Cited by 49
Mattioli, L., Titomanlio, F., & Perfumi, M. C. (2012) · Psychopharmacology · doi:10.1007/s00213-012-2686-0 · Cited by 49
Mephedrone (“bath salt”) pharmacology: insights from invertebrates
Ramoz, L. L., Lodi, S., Bhatt, P., Reitz, A. B., Tallarida, C., Tallarida, R. J., Raffa, R. B., & Rawls, S. M. (2012) · Neuroscience · doi:10.1016/j.neuroscience.2012.01.019 · Cited by 49
MicroRNA expression signature of methamphetamine use and addiction in the rat nucleus accumbens
Sim, M. S., Soga, T., Pandy, V., Wu, Y. S., Parhar, I. S., & Mohamed, Z. (2017) · Metabolic Brain Disease · doi:10.1007/s11011-017-0061-x · Cited by 49
Lénárd, L., László, K., Kertes, E., Ollmann, T., Péczely, L., Kovács, A., Kállai, V., Zagorácz, O., Gálosi, R., & Karádi, Z. (2017) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2017.09.003 · Cited by 49
Metadata
- Authors
- Koob, G. F.
- Affiliations
- Scripps Research Institute (US)
- Corresponding author
- Koob, George F.
- Venue
- Trends in Pharmacological Sciences
- Publisher
- Elsevier BV
- Published
- 1992-01
- Volume
- 13
- Issue
- 5
- Pages
- 177-184
- ISSN
- 0165-6147 (ISSN-L)
- OpenAlex
- W2001865657
- Cited by
- 2,070
- References
- 73
- Citations by year
- 2026: 7 · 2025: 10 · 2024: 12 · 2023: 16 · 2022: 17 · 2021: 28 · 2020: 30 · 2019: 28 · 2018: 46 · 2017: 42 · 2016: 43 · 2015: 37 · 2014: 58 · 2013: 53 · 2012: 53
- FWCI
- 6.53
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Trends in Pharmacological Sciences (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute on Alcohol Abuse and Alcoholism (AA-08459)
- National Institute on Drug Abuse (DA04043, DA04398, R01DA004398, R01DA004043)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Life Sciences › Neuroscience › Cognitive Neuroscience › Neural and Behavioral Psychology Studies
- Keywords
- drugs of abuse, brain reward system, dopamine, opioid system, GABA, nucleus accumbens, ventral tegmental area, ethanol reward, opioid reward, operant responding
- MeSH terms
- Animals, Brain, Humans, Reward, Illicit Drugs, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review